Viewing Study NCT00011895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-17 @ 3:24 AM
Study NCT ID: NCT00011895
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-03-02
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None Drug Therapy, Combination View
None Zidovudine View
None Lamivudine View
None Drug Combinations View
None RNA, Viral View
None Reverse Transcriptase Inhibitors View
None Anti-HIV Agents View
None Viral Load View
None abacavir View
None efavirenz View